Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.
about
Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infectionGene expression profiling and network analysis reveals lipid and steroid metabolism to be the most favored by TNFalpha in HepG2 cells.Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune SystemInflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.Cystic fibrosis and Crohn's disease: successful treatment and long term remission with infliximab.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.Azithromycin increases survival and reduces lung inflammation in cystic fibrosis miceAzithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging studySuppressive effects of azithromycin on zymosan-induced production of proinflammatory mediators by human corneal epithelial cellsRelationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice.Pathogen- and host-directed anti-inflammatory activities of macrolide antibioticsMacrolide antibiotics like azithromycin increase lipopolysaccharide-induced IL-8 production by human gingival fibroblasts.Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.Adult onset lung disease following transient disruption of fetal stretch-induced differentiation.Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice.Bronchial brushings for investigating airway inflammation and remodelling.Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Anti-inflammatory effects of macrolides in childhood lung diseases.IL-17A in human respiratory diseases: innate or adaptive immunity? Clinical implications.Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cellsAnti-inflammatory activity of azithromycin as measured by its NF-kappaB, inhibitory activity.Azithromycin reduces tumor necrosis factor-alpha production in lipopolysaccharide-stimulated THP-1 monocytic cells by modification of stress response and p38 MAPK pathway.Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection.Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells.Effects of azithromycin on the expression of ATP binding cassette transporters in epithelial cells from the airways of cystic fibrosis patients.Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation.Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas.In Vitro Anti-inflammatory and Immunomodulatory Effects of Ciprofloxacin or Azithromycin in Staphylococcus aureus-Stimulated Murine Macrophages are Beneficial in the Presence of Cytochalasin D.Anti-inflammatory effects of four potential anti-endotoxaemic drugs assessed in vitro using equine whole blood assays.Pharmacokinetic-pharmacodynamic analysis of azithromycin extended release in Japanese patients with common respiratory tract infectious disease.Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.Antimicrobial activity of apple cider vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; downregulating cytokine and microbial protein expression.
P2860
Q28472320-6E7E8A31-C6FE-4089-8AE7-DD986DE925CCQ33530117-72021EC7-0F4B-4160-A7EE-FC4FE29D9DD8Q33664362-C0080749-0F95-424D-9BF2-C557A15FE67AQ33794333-514E4494-4ECF-49C0-9D24-2F6138A34762Q33798912-C5E9F1BC-6A6C-43C3-81D4-8BE026C9A396Q33983140-4C1918F9-224F-4306-B933-2FF601ACC65FQ34058316-E34FBA15-B7F5-406C-A2C3-88643503ABDFQ34185975-69F0BD82-039D-4F1D-A46D-52AF7DE73F42Q34292510-6239839A-2814-47DF-ACCC-A09FE3FB92B7Q34702025-ECB5B2B7-6DC0-4AC4-9237-A7A555DD9C25Q35385336-96DF6E33-35CE-4600-9D73-DF7A24336607Q35423526-592F71E9-F97C-40B3-A182-806C74C8BF0DQ36072425-5FCB27C8-7DB2-4893-8E4D-5281A5AE6B04Q36280919-A5F1EC8A-E85C-4448-9393-22BC805FAA54Q36723908-E037181A-60FF-468B-AAB8-F5406698AF2DQ36968815-B16C46E5-8B57-4515-81B6-E6FF8F9370C9Q37200409-7651C129-A495-43E1-90A7-225442370E03Q37607163-5ED8F3A1-3490-4AFC-B0F9-C925ACE71911Q37882032-0B06AEF5-06DF-4997-BA88-376C64ACAC01Q37959271-35ACA411-F043-4B1B-8FD3-09C4893CCC95Q38071534-75863692-9921-4EA1-A707-4D8D2A76C412Q38080843-9DA5B85F-9701-4B84-AB13-4A79B4D8EEC8Q38085248-862644BD-740E-4A60-9EFE-3309DCAE0941Q39456654-A8766DEE-60AC-4209-AB6B-4AE23D009F5BQ39744364-C0493E67-42A9-4524-9705-D1EC78278DC4Q39822510-BB6A005D-CEBA-4BD7-8836-E6DEBD1394AFQ39860101-8DF750E9-5792-4902-B868-C2DD9D74D5C8Q39903283-F7138CCC-013B-418C-97CE-DF7488AAFF49Q40019252-EA8A3CCA-C64B-4D78-B0AB-D61B1A115907Q40417231-0247FE8F-5045-4539-8FDE-70AC89F07250Q40749683-75FDF9D0-4AA7-4939-8EFD-8ED0B7C4D602Q41645682-83867930-CE5B-408F-A273-DCD5AB48DDA1Q41656623-4774F769-04EF-439E-9E96-83AB3327222FQ45364183-A36AA992-62C2-4092-9A1B-C010D2B96A52Q46108631-6032F772-04D0-4019-8AAD-8BABE4BE7203Q49328081-A8799065-8BC6-451F-9C6D-FE0FD7602779
P2860
Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Azithromycin selectively reduc ...... rosis airway epithelial cells.
@en
type
label
Azithromycin selectively reduc ...... rosis airway epithelial cells.
@en
prefLabel
Azithromycin selectively reduc ...... rosis airway epithelial cells.
@en
P2093
P2860
P356
P1476
Azithromycin selectively reduc ...... rosis airway epithelial cells.
@en
P2093
Baroukh Maurice Assael
Cristina Cigana
Paola Melotti
P2860
P304
P356
10.1128/AAC.01142-06
P407
P577
2007-01-08T00:00:00Z